Abstract：Objection To investigate the effect of miR-32-5p on the radiosensitivity, migration and invasion of colorectal cancer cells and the underlying mechanism. Methods Human colorectal cancer SW480 cells and normal colonic epithelial NCM460 cells were cultured. The colorectal cancer cells were divided into the non-transfected and transfected groups (transfected with anti-miR-NC, anti-miR-32-5p, pcDNA, pcDNA-TOB1, anti-miR-32-5p+si-NC and anti-miR-32-5p+si-TOB1, respectively). The expression of miR-32-5p and TOB1 at the mRNA and protein levels was detected by RT-qPCR and Western blot. The radiosensitivity of the transfected cells was determined by colony formation assay. The migration and invasion ability of the transfected cells were detected by Transwell assay. Whether miR-32-5p targeted TOB1 was validated by dual luciferase reporter gene assay and Western blot. Results Compared with human colonic epithelial cells, the expression of miR-32-5p was significantly up-regulated, whereas the expression of TOB1 mRNA and protein was remarkably down-regulated in the colon cancer cells (all P<0.05). Compared with the anti-miR-NC, the quantity of cell migration and invasion was significantly decreased (both P<0.05) and the radiosensitivity ratio was 1.801 in the anti-miR-32-5p group. Compared with the pcDNA group, the quantity of cell migration and invasion was significantly decreased (both P<0.05) and the radiosensitivity ratio was 1.764 in the pcDNA-TOB1 group. Dual luciferase reporter gene assay and Western blot confirmed that miR-32-5p negatively regulated the expression of TOB1 protein. Compared with the anti-miR-32-5p+si-NC group, the quantity of cell migration and invasion was significantly increased (both P<0.05) and the radiosensitivity ratio was 0.591 in the anti-miR-32-5p+si-TOB1 group. Conclusions Inhibition of miR-32-5p expression can significantly enhance the radiosensitivity of colorectal cancer cells and suppress cell migration and invasion. The underlying mechanism might be related to the targeted up-regulation of TOB1 expression.
Zhang Hui,Liang Hong,Zhang Chao. Mechanism of miR-32-5p targeting TOB1 gene in regulating radiosensitization, migration and invasion of colorectal cancer cells[J]. Chinese Journal of Radiation Oncology, 2020, 29(2): 118-121.
[1] Wu W,Yang J,Feng X,et al. MicroRNA-32(miR-32) regμlates phosphatase and tensin homologue (PTEN) expression and promotes growth,migration,and invasion in colorectal carcinoma cells[J]. Mol Cancer,2013,12(1):30-41. DOI:10.1186/1476-4598-12-30.
[2] Guan R,Lei P,Dong W,et al. Decreased TOB1 expression and increased phosphorylation of nuclear TOB1 promotes gastric cancer[J]. Oncotarget,2017,8(43):75243-75253. DOI:10.18632/oncotarget.20749.
[3] 宋贺,于景翠. TOB1基因功能及其与肿瘤关系的研究进展[J]. 肿瘤学杂志,2018,24(4):375-379. DOI:10.11735/j.issn.1671-170X.2018.04. B017.
Song H,Yu JC. Research progress of the function of TOB1 gene and its association with tumor[J]. J Chin Oncol,2018,24(4):375-379. DOI:10.11735/j.issn.1671-170X.2018.04. B017.
[4] 梁高峰,李俊生,何向峰,等. 基于高通量测序的结直肠癌 miRNA表达谱分析[J]. 郑州大学学报(医学版,2015,50(5):618-623. DOI:10.13705/j.issn.1671-6825.2015.05.007.
Liang GF,Li JS,He XF,et al. Analysis of miRNA expression profi les in colorectal cancer based on high-throughput seque ncing[J]. J Zhengzhou Univ (Med Sci),2015,50(5):618-623. DOI:10.13705/j.issn.1671-6825.2015.05.007.
[5] 张玉虹,李皓,刘阳晨.miRNA在肿瘤放疗敏感性中的作用及机制[J]. 现代肿瘤医学,2016,24(2):314-318. DOI:10.3969/j.issn.1672-4992.2016.02.045.
Zhang YH,Li H,Liu YC. The functionand mechanism of miRNA in tumor radiosensitivity[J]. J Mod Oncol,2016,24(2):314-318. DOI:10.3969/j.issn.1672-4992.2016.02.045.
[6] Koo T,Cho BJ,Dan HK,et al. MicroRNA-200c increases radiosensitivity of human cancer cells with activated EGFR-associated signaling[J]. Oncotarget,2017,8(39):65457-65468. DOI:10.18632/oncotarget.18924.
[7] Chen X,Xu Y,Liao X,et al. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer[J]. Tumour Biol,2016,37(9):11927-11936. DOI:10.1007/s13277-016-5052-8.
[8] 林水苗,夏琼,张余琴,等. MiR-124通过靶向PRRX1调节结直肠癌细胞的辐射敏感性[J]. 南方医科大学学报,2016,36(8):1110-1116. DOI:10.3969/j.issn.1673-4254.2016.08.15.
Lin SM,Xia Q,Zhang YQ,et al.[miR-124 regμlates radiosensitivity of colorectal cancer cells by targeting PRRX1][J]. J South Med Univ,2016,36(8):1110-1116.
[9] Li Z,Jiangtao C,Zhongyong Z,et al.miR-195 enhances the radiosensitivity of colorectal cancer cells by suppressing CARM1[J]. Onco Targets Ther,2017,10:1027-1038. DOI:10.2147/OTT. S125067.
[10] Lu Z,Xiaojie L,Yμlin C,et al. KLF4,a miR-32-5p targeted gene,promotes cisplatin-induced apoptosis by upregμlating BIK expression in prostate cancer[J]. Cell Commun Sign,2018,16(1):53-62. DOI:10.1186/s12964-018-0270-x.
[11] 何洪杰,于景翠. 抗增殖家族成员TOB1基因与肿瘤[J]. 临床肿瘤学杂志,2015,20(3):262-265. DOI:CNKI:SUN:LCZL.0.2015-03-016.
He HJ,Yu JC. TOB1 gene of antiproliferative family and cancer[J]. Chin Clin Oncol,2015,20(3):262-265. DOI:CNKI:SUN:LCZL.0.2015-03-016.
[12] 孙克康,仲宁,沈晓军,等. 顺铂对人结直肠癌细胞HCT-116中TOB1表达的影响[J]. 中国老年学杂志,2014,34(4):1010-1012. DOI:10.3969/j.issn.1005-9202.2014.04.069.
Sun KK,Zhong N,Shen XJ,et al. Effect of cisplatin on expression of TOB1 in hct-116 in human colorectal cancer cells[J]. Chin J Gerontol,2014,34(4):1010-1012. DOI:10.3969/j.issn.1005-9202.2014.04.069.
[13] Wu D,Zhou W,Wang S,et al. Tob1 enhances radiosensitivity of breast cancer cells involving the JNK and p38 pathways[J]. Cell Biol Int,2016,39(12):1425-1430. DOI:10.1002/cbin.10545.
[14] Sun KK,Zhong N,Yang Y,et al. Enhanced radiosensitivity of NSCLC cells by transducer of erbB2.1(TOB1) through modμlation of the MAPK/ERK pathway[J]. Oncol Rep,2013,29(6):2385-2391. DOI:10.3892/or.2013.2403.
2020, Vol. 29 
